Browsing by Author "Zorzi, Giovanna (6603821807)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation(2006) ;Hartig, Monika B. (12144454300) ;Hörtnagel, Konstanze (59867854200) ;Garavaglia, Barbara (7004612048) ;Zorzi, Giovanna (6603821807) ;Kmiec, Tomasz (6603716368) ;Klopstock, Thomas (6603746477) ;Rostasy, Kevin (55938543700) ;Svetel, Marina (6701477867) ;Kostic, Vladimir S. (35239923400) ;Schuelke, Markus (6701679466) ;Botz, Evelyn (8343207700) ;Weindl, Adolf (7005215115) ;Novakovic, Ivana (6603235567) ;Nardocci, Nardo (7003319824) ;Prokisch, Holger (6603080105)Meitinger, Thomas (57215631099)Objective: Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2). Methods: We completed a mutation screen in 72 patients with the diagnosis NBIA based on clinical findings and radiological imaging. The entire coding region of the PANK2 gene (20p12.3) was investigated for point mutations and deletions. Results: We uncovered both mutant alleles in 48 patients. Deletions accounted for 4% of mutated alleles. Patients with two loss-of-function alleles (n = 11) displayed symptoms always at an early stage of life. In the presence of missense mutations (n = 37), the age of onset correlated with residual activity of the pantothenate kinase. Progression of disease measured by loss of ambulation was variable in both groups. We did not observe a strict correlation between the eye-of-the-tiger sign and PANK2 mutations. In 24 patients, no PANK2 mutation was identified. Interpretation: Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity. © 2006 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation(2006) ;Hartig, Monika B. (12144454300) ;Hörtnagel, Konstanze (59867854200) ;Garavaglia, Barbara (7004612048) ;Zorzi, Giovanna (6603821807) ;Kmiec, Tomasz (6603716368) ;Klopstock, Thomas (6603746477) ;Rostasy, Kevin (55938543700) ;Svetel, Marina (6701477867) ;Kostic, Vladimir S. (35239923400) ;Schuelke, Markus (6701679466) ;Botz, Evelyn (8343207700) ;Weindl, Adolf (7005215115) ;Novakovic, Ivana (6603235567) ;Nardocci, Nardo (7003319824) ;Prokisch, Holger (6603080105)Meitinger, Thomas (57215631099)Objective: Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2). Methods: We completed a mutation screen in 72 patients with the diagnosis NBIA based on clinical findings and radiological imaging. The entire coding region of the PANK2 gene (20p12.3) was investigated for point mutations and deletions. Results: We uncovered both mutant alleles in 48 patients. Deletions accounted for 4% of mutated alleles. Patients with two loss-of-function alleles (n = 11) displayed symptoms always at an early stage of life. In the presence of missense mutations (n = 37), the age of onset correlated with residual activity of the pantothenate kinase. Progression of disease measured by loss of ambulation was variable in both groups. We did not observe a strict correlation between the eye-of-the-tiger sign and PANK2 mutations. In 24 patients, no PANK2 mutation was identified. Interpretation: Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity. © 2006 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication Status dystonicus: Predictors of outcome and progression patterns of underlying disease(2012) ;Fasano, Alfonso (14422094000) ;Ricciardi, Lucia (36167347400) ;Bentivoglio, Anna Rita (57194264260) ;Canavese, Carlotta (54390841100) ;Zorzi, Giovanna (6603821807) ;Petrovic, Igor (7004083314) ;Kresojevic, Nikola (26644117100) ;Kostić, Vladimir S. (35239923400) ;Svetel, Marina (6701477867) ;Kovacs, Norbert (12645835600) ;Balas, Istvan (12646276700) ;Roubertie, Agathe (6603838523) ;Mishra, Devendra (7102272028) ;Mariotti, Paolo (55586019600) ;Temudo, Teresa (6602098088)Nardocci, Nardo (7003319824)Background: Status dystonicus (SD) is a rare, life-threatening disorder characterized by acute worsening of generalized dystonia. Methods: This study was conducted to characterize the pathogenesis, clinical course, and prognosis of SD. We reviewed the records of six centers and analyzed them together with all the cases previously reported in the literature. Results: Eighty-nine episodes occurring in 68 patients were studied. The majority of patients were males (64.7%), were <15 years of age (58.8%), and had secondary dystonia as the underlying condition (37.8%). The episodes were mainly characterized by tonic muscle spasms (68.5%), with phasic forms more common in secondary forms and among females. Almost all cases needed a multistaged approach, with surgery being the most successful strategy. Neurological conditions preceding the episode worsened in 16.2% of cases (ending in death in 10.3%). Conclusions: The course and outcome of SD is highly variable; male gender and prevalent tonic phenotype predict a poor outcome © 2012 Movement Disorder Society. - Some of the metrics are blocked by yourconsent settings
Publication Status dystonicus: Predictors of outcome and progression patterns of underlying disease(2012) ;Fasano, Alfonso (14422094000) ;Ricciardi, Lucia (36167347400) ;Bentivoglio, Anna Rita (57194264260) ;Canavese, Carlotta (54390841100) ;Zorzi, Giovanna (6603821807) ;Petrovic, Igor (7004083314) ;Kresojevic, Nikola (26644117100) ;Kostić, Vladimir S. (35239923400) ;Svetel, Marina (6701477867) ;Kovacs, Norbert (12645835600) ;Balas, Istvan (12646276700) ;Roubertie, Agathe (6603838523) ;Mishra, Devendra (7102272028) ;Mariotti, Paolo (55586019600) ;Temudo, Teresa (6602098088)Nardocci, Nardo (7003319824)Background: Status dystonicus (SD) is a rare, life-threatening disorder characterized by acute worsening of generalized dystonia. Methods: This study was conducted to characterize the pathogenesis, clinical course, and prognosis of SD. We reviewed the records of six centers and analyzed them together with all the cases previously reported in the literature. Results: Eighty-nine episodes occurring in 68 patients were studied. The majority of patients were males (64.7%), were <15 years of age (58.8%), and had secondary dystonia as the underlying condition (37.8%). The episodes were mainly characterized by tonic muscle spasms (68.5%), with phasic forms more common in secondary forms and among females. Almost all cases needed a multistaged approach, with surgery being the most successful strategy. Neurological conditions preceding the episode worsened in 16.2% of cases (ending in death in 10.3%). Conclusions: The course and outcome of SD is highly variable; male gender and prevalent tonic phenotype predict a poor outcome © 2012 Movement Disorder Society.
